Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Retained Earnings (2018 - 2026)

Exagen filings provide 9 years of Retained Earnings readings, the most recent being -$318.2 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 6.74% to -$318.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$318.2 million, a 6.74% decrease, with the full-year FY2025 number at -$314.3 million, down 6.78% from a year prior.
  • Retained Earnings hit -$318.2 million in Q1 2026 for Exagen, down from -$314.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$218.4 million in Q1 2022 to a low of -$318.2 million in Q1 2026.
  • Median Retained Earnings over the past 5 years was -$282.6 million (2024), compared with a mean of -$278.1 million.
  • Biggest five-year swings in Retained Earnings: fell 22.77% in 2022 and later dropped 5.41% in 2024.
  • Exagen's Retained Earnings stood at -$255.5 million in 2022, then dropped by 9.27% to -$279.2 million in 2023, then decreased by 5.41% to -$294.3 million in 2024, then dropped by 6.78% to -$314.3 million in 2025, then decreased by 1.25% to -$318.2 million in 2026.
  • The last three reported values for Retained Earnings were -$318.2 million (Q1 2026), -$314.3 million (Q4 2025), and -$309.6 million (Q3 2025) per Business Quant data.